| Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2, 5-dienones (‘quinols’) CJ Lion, CS Matthews, G Wells, TD Bradshaw, MFG Stevens, ... Bioorganic & medicinal chemistry letters 16 (19), 5005-5008, 2006 | 123 | 2006 |
| Oleuropein and derivatives from olives as Tau aggregation inhibitors A Daccache, C Lion, N Sibille, M Gerard, C Slomianny, G Lippens, ... Neurochemistry international 58 (6), 700-707, 2011 | 117 | 2011 |
| Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes CJ Lion, CS Matthews, MFG Stevens, AD Westwell Journal of medicinal chemistry 48 (4), 1292-1295, 2005 | 105 | 2005 |
| Magnesium Chelating 2-Hydroxyisoquinoline-1,3(2H,4H)-diones, as Inhibitors of HIV-1 Integrase and/or the HIV-1 Reverse Transcriptase Ribonuclease H Domain … M Billamboz, F Bailly, C Lion, N Touati, H Vezin, C Calmels, ML Andréola, ... Journal of medicinal chemistry 54 (6), 1812-1824, 2011 | 85 | 2011 |
| Insights into the Catalytic Activity of Nitridated Fibrous Silica (KCC‐1) Nanocatalysts from 15N and 29Si NMR Spectroscopy Enhanced by Dynamic Nuclear … AS Lilly Thankamony, C Lion, F Pourpoint, B Singh, AJ Perez Linde, ... Angewandte Chemie International Edition 54 (7), 2190-2193, 2015 | 73 | 2015 |
| 2-Hydroxyisoquinoline-1, 3 (2H, 4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4 M Billamboz, F Bailly, C Lion, C Calmels, ML Andréola, M Witvrouw, ... European journal of medicinal chemistry 46 (2), 535-546, 2011 | 58 | 2011 |
| 4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors M Billamboz, V Suchaud, F Bailly, C Lion, J Demeulemeester, C Calmels, ... ACS medicinal chemistry letters 4 (7), 606-611, 2013 | 36 | 2013 |
| α-Amino-β-fluorocyclopropanecarboxylic acids as a new tool for drug development: Synthesis of glutamic acid analogs and agonist activity towards metabotropic glutamate receptor 4 G Lemonnier, C Lion, JC Quirion, JP Pin, C Goudet, P Jubault Bioorganic & medicinal chemistry 20 (15), 4716-4726, 2012 | 33 | 2012 |
| Development of a series of 3-hydroxyquinolin-2 (1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity V Suchaud, F Bailly, C Lion, E Tramontano, F Esposito, A Corona, F Christ, ... Bioorganic & medicinal chemistry letters 22 (12), 3988-3992, 2012 | 33 | 2012 |
| 2-Hydroxyisoquinoline-1, 3 (2 H, 4 H)-diones (HIDs), novel inhibitors of HIV integrase with a high barrier to resistance BA Desimmie, J Demeulemeester, V Suchaud, O Taltynov, M Billamboz, ... ACS chemical biology 8 (6), 1187-1194, 2013 | 24 | 2013 |
| Investigation of a Novel Series of 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as Human Immunodeficiency Virus Type 1 Integrase Inhibitors V Suchaud, F Bailly, C Lion, C Calmels, ML Andréola, F Christ, Z Debyser, ... Journal of medicinal chemistry 57 (11), 4640-4660, 2014 | 21 | 2014 |
| NMR and EPR characterization of functionalized nanodiamonds C Presti, ASL Thankamony, JG Alauzun, PH Mutin, D Carnevale, C Lion, ... The Journal of Physical Chemistry C 119 (22), 12408-12422, 2015 | 20 | 2015 |
| A sequential bioorthogonal dual strategy: ManNAl and SiaNAl as distinct tools to unravel sialic acid metabolic pathways PA Gilormini, C Lion, D Vicogne, T Levade, S Potelle, C Mariller, ... Chemical Communications 52 (11), 2318-2321, 2016 | 19 | 2016 |
| Novel reaction products from the hypervalent iodine oxidation of hydroxylated stilbenes and isoflavones CJ Lion, DA Vasselin, CH Schwalbe, CS Matthews, MFG Stevens, ... Organic & biomolecular chemistry 3 (21), 3996-4001, 2005 | 17 | 2005 |
| BLISS: a bioorthogonal dual-labeling strategy to unravel lignification dynamics in plants C Lion, C Simon, B Huss, AS Blervacq, L Tirot, D Toybou, C Spriet, ... Cell chemical biology 24 (3), 326-338, 2017 | 13 | 2017 |
| New 2-arylnaphthalenediols and triol inhibitors of HIV-1 integrase—Discovery of a new polyhydroxylated antiviral agent C Maurin, C Lion, F Bailly, N Touati, H Vezin, G Mbemba, JF Mouscadet, ... Bioorganic & medicinal chemistry 18 (14), 5194-5201, 2010 | 13 | 2010 |
| Probing the CMP‐Sialic Acid Donor Specificity of Two Human β‐d‐Galactoside Sialyltransferases (ST3Gal I and ST6Gal I) Selectively Acting on O‐ and N … M Noel, PA Gilormini, V Cogez, N Yamakawa, D Vicogne, C Lion, C Biot, ... Chembiochem 18 (13), 1251-1259, 2017 | 9 | 2017 |
| 2-hydroxyisoquinoline-1, 3 (2H, 4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: influence of the alkylcarboxamide substitution of position 4 M Billamboz, V Suchaud, F Bailly, C Lion, ML Andreola, F Christ, ... European journal of medicinal chemistry 117, 256-268, 2016 | 7 | 2016 |
| Improved workflow for the efficient preparation of ready to use cmp-activated sialic acids PA Gilormini, C Lion, M Noel, MA Krzewinski-Recchi, A Harduin-Lepers, ... Glycobiology 26 (11), 1151-1156, 2016 | 4 | 2016 |
| BLISS: Shining a light on lignification in plants C Simon, C Lion, B Huss, AS Blervacq, C Spriet, Y Guérardel, C Biot, ... Plant signaling & behavior 12 (8), 326-338, 2017 | 3 | 2017 |
